Your browser is no longer supported. Please, upgrade your browser.
Settings
SGYP Synergy Pharmaceuticals Inc. daily Stock Chart
SGYP [NASD]
Synergy Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.64 Insider Own0.30% Shs Outstand246.99M Perf Week2.07%
Market Cap365.55M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float244.98M Perf Month-11.90%
Income-151.60M PEG- EPS next Q-0.13 Inst Own39.40% Short Float24.05% Perf Quarter-22.11%
Sales35.20M P/S10.38 EPS this Y17.60% Inst Trans-0.04% Short Ratio24.59 Perf Half Y-17.32%
Book/sh-0.26 P/B- EPS next Y39.60% ROA-112.00% Target Price6.24 Perf Year-51.32%
Cash/sh0.25 P/C5.97 EPS next 5Y- ROE548.90% 52W Range1.28 - 3.24 Perf YTD-33.63%
Dividend- P/FCF- EPS past 5Y-9.30% ROI-201.10% 52W High-54.32% Beta1.51
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin66.80% 52W Low15.63% ATR0.09
Employees313 Current Ratio2.80 Sales Q/Q434.80% Oper. Margin- RSI (14)40.90 Volatility7.42% 6.26%
OptionableYes Debt/Eq- EPS Q/Q63.40% Profit Margin- Rel Volume0.79 Prev Close1.38
ShortableYes LT Debt/Eq- EarningsNov 06 AMC Payout- Avg Volume2.40M Price1.48
Recom2.00 SMA20-6.24% SMA50-13.75% SMA200-20.16% Volume1,915,336 Change7.25%
Jan-05-18Downgrade Oppenheimer Outperform → Perform
Sep-25-17Reiterated H.C. Wainwright Buy $15 → $8
Sep-13-17Reiterated Citigroup Sell $3.20 → $2.50
Sep-08-17Reiterated Oppenheimer Outperform $9 → $6
Aug-10-17Reiterated Rodman & Renshaw Buy $18 → $15
Apr-06-17Downgrade Citigroup Neutral → Sell
Jan-20-17Reiterated Rodman & Renshaw Buy $17 → $18
Jan-05-17Initiated Oppenheimer Outperform
Dec-23-16Reiterated Rodman & Renshaw Buy $16 → $17
Dec-18-15Downgrade Citigroup Buy → Neutral
Oct-29-15Resumed ROTH Capital Buy $9.50
Jun-18-15Reiterated Canaccord Genuity Buy $11 → $19
May-22-15Initiated Canaccord Genuity Buy $11
Nov-18-14Reiterated ROTH Capital Buy $8.50 → $6
Aug-12-13Reiterated Cantor Fitzgerald Buy $15 → $11
Apr-09-13Reiterated Cantor Fitzgerald Buy $12 → $15
Jan-02-13Reiterated Cantor Fitzgerald Buy $7 → $13
Sep-25-12Initiated Cantor Fitzgerald Buy $7
Oct-08-18 08:00AM  Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at the American College of Gastroenterology (ACG) Annual Scientific Meeting Business Wire
Oct-03-18 09:41AM  Is the Options Market Predicting a Spike in Synergy Pharmaceuticals (SGYP) Stock? Zacks
Oct-01-18 09:30AM  Synergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG) Annual Scientific Meeting Business Wire
Sep-24-18 08:00AM  Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access Wins Business Wire
Sep-19-18 03:03PM  Shareholders Should Check If Insiders Own Shares In Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Simply Wall St.
Sep-11-18 09:12AM  Here's Why Synergy Pharmaceuticals Rose 14.1% in August Motley Fool
Aug-31-18 08:46AM  Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock? Zacks
08:00AM  Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Aug-07-18 09:22PM  CORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update Business Wire
08:10PM  Synergy Pharmaceuticals (SGYP) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:07PM  Synergy Pharma: 2Q Earnings Snapshot Associated Press
09:00AM  Synergy Pharmaceuticals Announces TRULANCE® (plecanatide) Added to Express Scripts 2019 National Preferred Formulary List Business Wire
06:00AM  Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China Business Wire
Jul-30-18 07:10AM  Initiating Free Research Reports on Synergy Pharma and Three Other Drug Makers Equities ACCESSWIRE
Jul-27-18 08:50AM  Is the Options Market Predicting a Spike in Synergy Pharmaceuticals (SGYP) Stock? Zacks
07:40AM  Market Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-06-18 09:05AM  Implied Volatility Surging for Synergy Pharmaceuticals (SGYP) Stock Options Zacks +5.46%
Jun-28-18 07:35AM  Initiating Free Research Reports on Canopy Growth and Three Other Drug Makers Equities ACCESSWIRE +5.56%
Jun-13-18 07:30AM  Synergy Pharmaceuticals Announces Amendment to CRG Debt Agreement Business Wire
Jun-06-18 08:20AM  Today's Research Reports on Trending Tickers: Synergy Pharmaceuticals and Mylan N.V. ACCESSWIRE
Jun-05-18 09:45AM  Synergy Pharmaceuticals to Present New Analysis of Therapeutic Risk and Benefit of TRULANCE® (plecanatide) and Linaclotide in Chronic Idiopathic Constipation (CIC) Patients at Digestive Disease Week (DDW) Business Wire +7.59%
09:30AM  Synergy Pharmaceuticals Highlights New Data at Digestive Disease Week (DDW) 2018 Linking Uroguanylin Deficiency to Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
May-29-18 08:30AM  Synergy Pharmaceuticals to Present New Data at Digestive Disease Week (DDW) Business Wire
May-24-18 08:45AM  Implied Volatility Surging for Synergy Pharmaceuticals (SGYP) Stock Options Zacks
May-22-18 07:53AM  Biotech CEO Presents: Mercks $500M Pain, Our Potential Gain ACCESSWIRE
May-18-18 07:25AM  Free Stock Performance Review on Teva Pharma and Three Other Healthcare Sector ACCESSWIRE
May-17-18 03:55PM  Synergy Pharmaceuticals Inc (NASDAQ:SGYP): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St. -5.14%
May-14-18 03:52PM  Edited Transcript of SGYP earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
08:00AM  Todays Research Reports on Stocks to Watch: Regeneron Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE
May-11-18 08:30AM  Today's Research Reports on Trending Tickers: Intrexon Corporation and Synergy Pharmaceuticals ACCESSWIRE +15.95%
May-10-18 06:24PM  Synergy Pharma: 1Q Earnings Snapshot Associated Press
04:15PM  Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update Business Wire
Apr-25-18 08:30AM  Synergy Pharmaceuticals to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast Business Wire
Apr-18-18 08:51AM  Options Traders Expect Huge Moves in Synergy Pharmaceuticals (SGYP) Stock Zacks
Apr-11-18 08:00AM  Biotech Guru Samuel Isaly Bets on scPharmaceuticals (SCPH), Throws in the Towel on Synergy Pharmaceuticals (SGYP) Investopedia
Apr-10-18 10:45AM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Reminds Investors With Losses In Excess of $50,000 to Contact The Firm ACCESSWIRE
10:30AM  Glancy Prongay & Murray LLP Reminds Investors of the April 10, 2018 Deadline in the Class Action Lawsuit Against Synergy Pharmaceuticals Inc. (SGYP) Business Wire
10:05AM  SGYP DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
10:00AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 GlobeNewswire
Apr-09-18 06:56PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP) Business Wire
05:19PM  EQUITY NOTICE: Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action SGYP Business Wire
03:38PM  FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm ACCESSWIRE
03:30PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th ACCESSWIRE
03:03PM  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 SGYP ACCESSWIRE
Apr-07-18 01:30PM  DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-06-18 06:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:41AM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-05-18 05:30PM  Synergy Pharmaceuticals Inc. Reminder: Important April 10, 2018 Lead Plaintiff Deadline in Class Action SGYP ACCESSWIRE
04:28PM  SGYP UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:25AM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP: Final Deadline Reminder For Synergy Pharmaceuticals Inc. Shareholders - SGYP ACCESSWIRE
Apr-04-18 04:15PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th ACCESSWIRE
03:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline SGYP Business Wire
02:18PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
12:42PM  TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-03-18 03:40PM  The Klein Law Firm Reminds Investors of Commencement of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:35AM  7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Apr-02-18 09:22PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP) Business Wire
03:08PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
11:30AM  DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders ACCESSWIRE
10:44AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Apr-01-18 06:00AM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Synergy Pharmaceuticals Inc. to Contact the Firm Business Wire
Mar-31-18 12:00PM  3 Favorite Biotech Stocks for the Second Quarter TheStreet.com
11:05AM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
06:27AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-30-18 01:50PM  IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
Mar-29-18 03:28PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
Mar-28-18 05:25PM  APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm ACCESSWIRE
02:45PM  The Klein Law Firm Reminds Investors of the Commencement of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
01:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:00AM  Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Synergy Pharmaceuticals Inc. on Behalf of Shareholders ACCESSWIRE
Mar-27-18 06:19PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Business Wire
Mar-26-18 03:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Commencement of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:50AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-24-18 04:06PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-23-18 12:58PM  Synergy Pharmaceuticals Inc (NASDAQ:SGYP): Is Breakeven Near? Simply Wall St.
Mar-22-18 03:12PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
08:00AM  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Synergy Pharmaceuticals Inc. Shareholders SGYP GlobeNewswire
Mar-21-18 08:22PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
11:36AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:21AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) and Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-20-18 03:22PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Synergy Pharmaceuticals Inc. Shareholders and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
Mar-19-18 05:33PM  DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Encourages Investors With Losses To Contact The Firm ACCESSWIRE
04:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
11:47AM  Synergy Pharmaceuticals Inc. Investors: Important April 10, 2018 Lead Plaintiff Deadline in Class Action- SGYP ACCESSWIRE
Mar-17-18 05:36PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-16-18 04:10PM  SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. GlobeNewswire
Mar-15-18 01:27PM  SGYP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 GlobeNewswire
10:20AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) and Lead Plaintiff Deadline: April 10, 2018 ACCESSWIRE
Mar-14-18 07:14PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 SGYP GlobeNewswire
05:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-13-18 03:31PM  Lifshitz & Miller LLP Announces Investigation of A. Schulman, Inc., CSRA Inc., Infinity Property and Casualty Corporation, Layne Christensen Company, Microsemi Corporation, Quantum Corporation, and Synergy Pharmaceuticals Inc. PR Newswire
08:30AM  Synergy Pharmaceuticals to Present at Oppenheimer 28th Annual Healthcare Conference Business Wire
Mar-11-18 10:10AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
Mar-09-18 11:36AM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Encourages Investors With Losses To Contact The Firm ACCESSWIRE
11:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP ACCESSWIRE
10:07AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018 GlobeNewswire
Mar-08-18 03:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP ACCESSWIRE
02:10PM  SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018 ACCESSWIRE
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin based gastrointestinal platform that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. It has a licensing agreement with Cipher Pharmaceuticals Inc. to develop, market, distribute, and sell TRULANCE in Canada. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spigelman Melvin KDirectorAug 15Option Exercise1.20150,000180,000150,000Aug 16 05:00 PM
BRANCACCIO JOHN PDirectorJul 04Option Exercise0.5050,02325,012130,467Jul 06 04:31 PM
ADAMS THOMAS PHDDirectorJul 03Option Exercise0.50100,02350,012100,023Jul 06 04:31 PM
JACOB GARY SExecutive ChairmanJun 15Option Exercise0.50474,961237,481877,640Jun 18 04:30 PM
BRANCACCIO JOHN PDirectorApr 02Option Exercise0.5050,00025,00076,944Apr 02 05:00 PM
PAULSON & CO. INC.10% OwnerNov 10Sale2.828,750,00024,678,50015,312,368Nov 14 04:36 PM